All UW investigators participating in research involving UW facilities or resources or patients receiving care at the UW are subject to
GIM 10, the UW's Significant Financial Interest Disclosure Policy.
As part of GIM 10, if any investigator has a significant financial interest related to the research, it must be indicated on the
eGC1 and the interest must be disclosed using the
Significant Financial Interest Disclosure Form.
The definition of a significant financial interest is different for clinical trials, which has a zero threshold. In addition, the UW Human Subjects Review Committee Application has specific questions regarding investigator financial interests.
School of Medicine faculty are also prohibited from serving as an author on any publication in which ghost authorship has occurred. Refer to the
Ghost Author Policy for more information.